These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2352446)
1. Effects of drugs affecting cholesterol biosynthesis pathway on BM 15.766-induced 7-dehydrocholesterol accumulation in rats. An animal model for testing compounds reducing cholesterol synthesis. Pill J; Stegmeier K; Schmidt FH Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):167-74. PubMed ID: 2352446 [TBL] [Abstract][Full Text] [Related]
2. Reduction of BM 15.766-induced 7-dehydrocholesterol accumulation by bezafibrate and mevinolin in rats. A non-isotopic in vivo test system for compounds reducing cholesterol synthesis. Pill J; Witte EC; Schmidt FH Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):552-6. PubMed ID: 2392158 [TBL] [Abstract][Full Text] [Related]
3. Regulation of the last two enzymatic reactions in cholesterol biosynthesis in rats: effects of BM 15.766, cholesterol, cholic acid, lovastatin, and their combinations. Honda A; Shefer S; Salen G; Xu G; Batta AK; Tint GS; Honda M; Chen TC; Holick MF Hepatology; 1996 Aug; 24(2):435-9. PubMed ID: 8690416 [TBL] [Abstract][Full Text] [Related]
4. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities. Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931 [TBL] [Abstract][Full Text] [Related]
5. Blocking late cholesterol biosynthesis inhibits the growth of transplanted Morris hepatomas (7288CTC) in rats. Xu G; Salen G; Lea M; Tint GS; Nguyen LB; Batta AK; Chen TS; Shefer S Hepatology; 1996 Aug; 24(2):440-5. PubMed ID: 8690417 [TBL] [Abstract][Full Text] [Related]
6. [Elevation of 7-dehydrocholesterol concentrations in serum and liver and pericentral peroxisome proliferation in hepatocytes of rats after inhibition of cholesterol biosynthesis by BM 15,766]. Weiss MC; Baumgart E; Fahimi HD; Pill H; Rebel W; Hartig F Berl Munch Tierarztl Wochenschr; 1995 Feb; 108(2):66-9. PubMed ID: 7786281 [TBL] [Abstract][Full Text] [Related]
7. The effects of BM 15.766, an inhibitor of 7-dehydrocholesterol delta 7-reductase, on cholesterol biosynthesis in primary rat hepatocytes. Aufenanger J; Pill J; Schmidt FH; Stegmeier K Biochem Pharmacol; 1986 Mar; 35(6):911-6. PubMed ID: 3754141 [TBL] [Abstract][Full Text] [Related]
8. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase. Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381 [TBL] [Abstract][Full Text] [Related]
9. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome. Salen G; Tint GS; Xu G; Batta AK; Irons M; Elias ER Ital J Gastroenterol; 1995 Dec; 27(9):506-8. PubMed ID: 8919321 [TBL] [Abstract][Full Text] [Related]
10. Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats. Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Tint GS J Clin Invest; 1995 Jan; 95(1):76-81. PubMed ID: 7814648 [TBL] [Abstract][Full Text] [Related]
11. Species differences in the inhibiting effect of fluvastatin, a new inhibitor of HMG-CoA reductase, on cholesterol biosynthesis. Yamamoto A; Itoh S; Hoshi K; Ichihara K Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):325-34. PubMed ID: 7712108 [TBL] [Abstract][Full Text] [Related]
12. Cholesterol biosynthesis inhibited by BM15.766 induces holoprosencephaly in the rat. Kolf-Clauw M; Chevy F; Siliart B; Wolf C; Mulliez N; Roux C Teratology; 1997 Sep; 56(3):188-200. PubMed ID: 9358606 [TBL] [Abstract][Full Text] [Related]
13. Effects of simvastatin, a cholesterol synthesis inhibitor, on phosphatidylcholine synthesis in HepG2 cells. Yanagita T; Yamamoto K; Ishida S; Sonda K; Morito F; Saku K; Sakai T Clin Ther; 1994; 16(2):200-8. PubMed ID: 8062316 [TBL] [Abstract][Full Text] [Related]
15. Effect of policosanol on the hepatic cholesterol biosynthesis of normocholesterolemic rats. Menendez R; Amor AM; Gonzalez RM; Fraga V; Mas R Biol Res; 1996; 29(2):253-7. PubMed ID: 9278716 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro. Flint OP; Masters BA; Gregg RE; Durham SK Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828 [TBL] [Abstract][Full Text] [Related]
17. Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin. De Vries AC; Vermeer MA; Bredman JJ; Bär PR; Cohen LH Exp Eye Res; 1993 Apr; 56(4):393-9. PubMed ID: 8500554 [TBL] [Abstract][Full Text] [Related]
19. A cholesterol deficiency syndrome in humans. Connor WE J Clin Invest; 1995 Jan; 95(1):2. PubMed ID: 7814615 [No Abstract] [Full Text] [Related]
20. Mode of action of terbufibrol (INN) a hypolipidemic agent on rat liver sterol synthesis. Löser R; Schliack M; Moreth W Artery; 1982; 10(3):180-92. PubMed ID: 7201785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]